Kyle C. Elrod
Chief Operating Officer at FORTY SEVEN, INC.
Kyle C. Elrod active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FORTY SEVEN, INC. | Chief Operating Officer | - | - |
Career history of Kyle C. Elrod
Former positions of Kyle C. Elrod
| Companies | Position | Start | End |
|---|---|---|---|
Celera Pharmaceuticals
 Celera Pharmaceuticals Pharmaceuticals: MajorHealth Technology Celera Pharmaceuticals manufactures pharmaceutical products. | Corporate Officer/Principal | - | - |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Corporate Officer/Principal | - | - |
| ARRIS GROUP INC | Chief Tech/Sci/R&D Officer | - | - |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - | - |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - | - |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Chief Operating Officer | 19/04/2012 | - |
| Corporate Officer/Principal | 01/11/2006 | 19/04/2012 |
Training of Kyle C. Elrod
| University of California, Berkeley | Undergraduate Degree |
Statistics
International
| United States | 9 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 7 |
| Electronic Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 7 |
|---|---|
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
ARRIS Group, Inc.
 ARRIS Group, Inc. Telecommunications EquipmentElectronic Technology ARRIS Group, Inc. operates as a global communications technology firm. It specializes in the design and engineering of broadband networks. The firm's products include video processing and delivery, broadband delivery, access networking, broadband and video devices, and customer experience management. The company was founded in 2001 and is headquartered in DE. | Electronic Technology |
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Celera Pharmaceuticals
Celera Pharmaceuticals Pharmaceuticals: MajorHealth Technology Celera Pharmaceuticals manufactures pharmaceutical products. | Health Technology |
- Stock Market
- Insiders
- Kyle C. Elrod
- Experience
